Search Results

There are 33559 results for: content related to: Interferon beta induces interleukin-10 expression: Relevance to multiple sclerosis

  1. Cytokine profile in interferon-β treated multiple sclerosis patients: reduction of interleukin-10 mRNA expressing cells in peripheral blood

    European Journal of Neurology

    Volume 4, Issue 6, November 1997, Pages: 567–571, M. Andersson, M. Khademi, E. Wallström and T. Olsson

    Article first published online : 20 JAN 2011, DOI: 10.1111/j.1468-1331.1997.tb00407.x

  2. Neuropsychological effects of interferon β-1a in relapsing multiple sclerosis

    Annals of Neurology

    Volume 48, Issue 6, December 2000, Pages: 885–892, Jill S. Fischer, Roger L. Priore, Lawrence D. Jacobs, Diane L. Cookfair, Richard A. Rudick, Robert M. Herndon, John R. Richert, Andres M. Salazar, Donald E. Goodkin, Carl V. Granger, Jack H. Simon, Jordan H. Grafman, Muriel D. Lezak, Kathleen M. O'Reilly Hovey, Katherine Kawczak Perkins, Danielle Barilla-Clark, Mark Schacter, David W. Shucard, Anna L. Davidson, Karl E. Wende, Dennis N. Bourdette and Mariska F. Kooijmans-Coutinho

    Article first published online : 23 MAR 2001, DOI: 10.1002/1531-8249(200012)48:6<885::AID-ANA9>3.0.CO;2-1

  3. Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis

    Annals of Neurology

    Volume 43, Issue 1, January 1998, Pages: 79–87, Dr Jack H. Simon, Lawrence D. Jacobs, Marilyn Campion, Karl Wende, Nancy Simonian, Diane L. Cookfair, Richard A. Rudick, Robert M. Herndon, John R. Richert, Andres M. Salazar, John J. Alam, Jill S. Fischer, Donald E. Goodkin, Carl V. Granger, Michelle Lajaunie, Anna L. Martens-Davidson, Maryjoel Meyer, Jeanelle Sheeder, Kim Choi, Ann L. Scherzinger, David M. Bartoszak, Dennis N. Bourdette, Jonathan Braiman, Carol M. Brownscheidle, Michael E. Coats, Stanley L. Cohan, David S. Dougherty, Revere P. Kinkel, Michele K. Mass, Fredrick E. Munschauer III, Roger L. Priore Scd, Patrick M. Pullicino, Barbara J. Scherokman, Bianca Weinstock-Guttman and Ruth H. Whitham

    Article first published online : 8 OCT 2004, DOI: 10.1002/ana.410430114

  4. Clinical outcomes assessment in multiple sclerosis

    Annals of Neurology

    Volume 40, Issue 3, September 1996, Pages: 469–479, Dr Richard Rudick, Jill Fischer, Jack Antel, Christian Confavreux, Gary Cutter, George Ellison, Fred Lublin, Aaron Miller, John Petkau, Stephen Rao, Stephen Reingold, Karl Syndulko, Alan Thompson, Joy Wallenberg, Brain Weinshenker and Ernest Willoughby

    Article first published online : 8 OCT 2004, DOI: 10.1002/ana.410400321

  5. Amelioration of flulike symptoms at the onset of interferon β- 1b therapy in multiple sclerosis by low-dose oral steroids is related to a decrease in interleukin-6 induction

    Annals of Neurology

    Volume 44, Issue 4, October 1998, Pages: 682–685, Dr. E. M. MartíNez-CáCeres, J. Río, M. Barrau, I. Durán, C. Borrás, M. Tintoré and X. Montalban

    Article first published online : 8 OCT 2004, DOI: 10.1002/ana.410440415

  6. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis

    Annals of Neurology

    Volume 39, Issue 3, March 1996, Pages: 285–294, Dr. Lawrence D. Jacobs, Diane L. Cookfair, Richard A. Rudick, Robert M. Herndon, John R. Richert, Andres M. Salazar, Jill S. Fischer, Donald E. Goodkin, Carl V. Granger, Jack H. Simon, John J. Alam, David M. Bartoszak, Dennis N. Bourdette, Jonathan Braiman, Carol M. Brownscheidle, Michael E. Coats, Stanley L. Cohan, David S. Dougherty, Revere P. Kinkel, Michele K. Mass, Frederick E. Munschauer III, Roger L. Priore, Patrick M. Pullicino, Barbara J. Scherokman, Bianca Weinstock-Guttman and Ruth H. Whitham

    Article first published online : 8 OCT 2004, DOI: 10.1002/ana.410390304

  7. The effects of interferon-β on interleukin-10 in multiple sclerosis patients

    European Journal of Neurology

    Volume 12, Issue 3, March 2005, Pages: 208–211, E. Ersoy, C. N. S. Kuş, U. Şener, I. Çoker and Y. Zorlu

    Article first published online : 3 FEB 2005, DOI: 10.1111/j.1468-1331.2004.00986.x

  8. Immunogenicity of interferon-β in multiple sclerosis patients: Influence of preparation, dosage, dose frequency, and route of administration

    Annals of Neurology

    Volume 48, Issue 5, November 2000, Pages: 706–712, Christian Ross, Katja Maria Clemmesen, Morten Svenson, Per Soelberg Sørensen, Nils Koch-Henriksen, Gunhild Lange Skovgaard and Klaus Bendtzen

    Article first published online : 4 APR 2001, DOI: 10.1002/1531-8249(200011)48:5<706::AID-ANA3>3.0.CO;2-V

  9. Validation of 1-year predictive score of long-term response to interferon-β in everyday clinical practice multiple sclerosis patients

    European Journal of Neurology

    M. Romeo, V. Martinelli, M. Rodegher, E. Perego, S. Maida, M. P. Sormani, G. Comi and San Raffaele Multiple Sclerosis Clinical Group

    Article first published online : 6 APR 2015, DOI: 10.1111/ene.12695

  10. Interferon-β for multiple sclerosis: Long-term benefits?

    Annals of Neurology

    Volume 61, Issue 4, April 2007, Pages: 283–285, Richard A. Rudick and Gary Cutter

    Article first published online : 19 APR 2007, DOI: 10.1002/ana.21119

  11. Use of Imaging in Multiple Sclerosis

    European Handbook of Neurological Management

    M. Filippi, M. A. Rocca, D. L. Arnold, R. Bakshi, F. Barkhof, N. De Stefano, F. Fazekas, E. Frohman, J. S. Wolinsky, Pages: 45–62, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753279.ch6

  12. Natural interferon-β treatment of relapsing—remitting and secondary-progressive multiple sclerosis patients. A two-year study

    Acta Neurologica Scandinavica

    Volume 100, Issue 5, November 1999, Pages: 283–289, F. Patti, M. R. L'Episcopo, M. L. Cataldi and A. Reggio

    Article first published online : 29 JAN 2009, DOI: 10.1111/j.1600-0404.1999.tb00397.x

  13. Multiple Sclerosis

    Neuroimmunology in Clinical Practice

    Bernadette Kalman, Thomas H. Brannagan, Pages: 27–82, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470692363.ch3

  14. Multiple sclerosis: myelin basic protein induced mRNA expression of proinflammatory cytokines in mononuclear cells is suppressed by interferon-β 1b in vitro

    European Journal of Neurology

    Volume 4, Issue 5, September 1997, Pages: 460–467, P. Kivisäkk, W. Tian, S. Fredrikson, H. Link and M. Söderström

    Article first published online : 20 JAN 2011, DOI: 10.1111/j.1468-1331.1997.tb00385.x

  15. Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis

    Annals of Neurology

    Volume 77, Issue 3, March 2015, Pages: 425–435, Tomas Kalincik, Dana Horakova, Tim Spelman, Vilija Jokubaitis, Maria Trojano, Alessandra Lugaresi, Guillermo Izquierdo, Csilla Rozsa, Pierre Grammond, Raed Alroughani, Pierre Duquette, Marc Girard, Eugenio Pucci, Jeannette Lechner-Scott, Mark Slee, Ricardo Fernandez-Bolanos, Francois Grand'Maison, Raymond Hupperts, Freek Verheul, Suzanne Hodgkinson, Celia Oreja-Guevara, Daniele Spitaleri, Michael Barnett, Murat Terzi, Roberto Bergamaschi, Pamela McCombe, Jose Sanchez-Menoyo, Magdolna Simo, Tunde Csepany, Gabor Rum, Cavit Boz, Eva Havrdova, Helmut Butzkueven and on behalf of the MSBase Study Group

    Article first published online : 17 JAN 2015, DOI: 10.1002/ana.24339

  16. Current Disease-Modifying Treatment of Multiple Sclerosis

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 78, Issue 2, March/April 2011, Pages: 161–175, Joy Derwenskus

    Article first published online : 21 MAR 2011, DOI: 10.1002/msj.20239

  17. Therapeutic apheresis in neurological disorders

    Journal of Clinical Apheresis

    Volume 15, Issue 1-2, 2000, Pages: 74–128, Robert Weinstein

    Article first published online : 29 MAR 2000, DOI: 10.1002/(SICI)1098-1101(2000)15:1/2<74::AID-JCA6>3.0.CO;2-O

  18. You have free access to this content
    New natural history of interferon-β–treated relapsing multiple sclerosis

    Annals of Neurology

    Volume 61, Issue 4, April 2007, Pages: 300–306, Maria Trojano, Fabio Pellegrini, Aurora Fuiani, Damiano Paolicelli, Valentina Zipoli, Giovanni B. Zimatore, Elisabetta Di Monte, Emilio Portaccio, Vito Lepore, Paolo Livrea and Maria Pia Amato

    Article first published online : 19 APR 2007, DOI: 10.1002/ana.21102

  19. Shifting imaging targets in multiple sclerosis: From inflammation to neurodegeneration

    Journal of Magnetic Resonance Imaging

    Volume 36, Issue 1, July 2012, Pages: 1–19, René M. Vigeveno, Oliver T. Wiebenga, Mike P. Wattjes, Jeroen J.G. Geurts and Frederik Barkhof

    Article first published online : 13 JUN 2012, DOI: 10.1002/jmri.23578

  20. Contrasting responses to interferon β-1b treatment in relapsing-remitting multiple sclerosis: Does baseline interleukin-12p35 messenger RNA predict the efficacy of treatment?

    Annals of Neurology

    Volume 48, Issue 3, September 2000, Pages: 313–322, A. H. H. Van Boxel-Dezaire, S. C. J. Van Trigt-Hoff, J. Killestein, H. M. Schrijver, J. C. Van Houwelingen, C. H. Polman and L. Nagelkerken

    Article first published online : 15 MAR 2001, DOI: 10.1002/1531-8249(200009)48:3<313::AID-ANA5>3.0.CO;2-9